Found 412 hits.
| 52. | Maurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. J., Greaves, M. W., Hide, M., Kalogeromitros, D., Kaplan, A. P., Saini, S. S., Zhu, X. J., and Zuberbier, T.: Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy 2011: 66; 317-330. IF: 6.27 |
r.052
| 197 | Rogala, B., Bozek, A.+, Glück, J., Rymarczyk, B., Jarzab, J., and Maurer, M.: Coexistence of angioedema alone with impaired glucose tolerance. Int. Arch. Allergy Immunol. 2014: 165; 265-269. IF: 2.67 |
o.197
| 274 | Maurer, M.*, Staubach, P.*, Raap, U.*, Richter-Huhn, G.*, Bauer, A., Ruëff, F., Jakob, T., Yazdi, A. S., Mahler, V., Wagner, N., Lippert, U., Hillen, U., Schwinn, A., Pawlak, M., Behnke, N., Chaouche, K., and Chapman-Rothe, N.: H1-antihistamine-refractory chronic spontaneous urticaria: It’s worse than we thought – first results of the multicenter real-life AWARE study. Clin. Exp. Allergy 2017: 47; 684-692. IF: 5.16 |
| 43 | Staubach, P., Eckhardt-Henn, A., Dechene, M., Hanau, A., Metz, M., Magerl, M., Breuer, P., and Maurer, M.+: Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Brit. J. Dermatol. 2006: 154; 294-298. IF: 3.33 |
| 126. | Kolkhir, P., Metz, M., Altrichter, S., and Maurer, M.+: Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: a systematic review. Allergy 2017: 72; 1440-1460. IF: 6.05 |
| 46. | Mrabet-Dahbi, S. and Maurer, M.: Does allergy impair innate immunity? Leads and lessons from atopic dermatitis. Allergy 2010: 65; 1351-1356. IF: 6.29 |
| 412. | Agache, I.+, Rocha, C., Pereira, A., Song, Y., Alonso-Coello, P., Solà, I., Beltran, J., Posso, M., Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger, T., Eyerich, K., Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P., O’Mahony, L., Schwarze, J., Werfel, T., Canelo-Aybar, C., Palomares, O., and Jutel, M.: Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines. Allergy 2021: 76; 59-70. IF: 14.71 |
o.412
| 135. | Dressler, C., Werner, R. N., Eisert, L., Zuberbier, T., Nast, A., and Maurer, M.+: Chronic inducible urticaria: a systematic review of treatment options. J. Allergy Clin. Immunol. 2018: 141; 1726-1734. IF: 14.11 |
| 133. | Siiskonen, H., Smorodchenko, A., Krause, K., and Maurer, M.: Ultraviolet radiation and skin mast cells: effects, mechanisms, and relevance for skin diseases. Exp. Dermatol. 2018:27; 3-8. IF: 2.87 |
r.133
| 23. | Church, M. K. and Maurer M.: Action protectrice des éthers phénoliques au course de l’intoxication histaminique (Protective action of phenolic ethers on the course of histamine intoxication) D Bovet and Mlle A-M Staub (20). In: Sheikh, A., Platts-Mills, T., and Worth, A., editors: Landmarks in Allergy Seminal Papers in Allergy with Expert Commentaries. Oxford: University Press, 2013 |